Tags » Beta-amyloid

New drug in clinical trials reduces senile plaque that is formed from beta-amyloid

Lancaster University says that a new drug that may help to prevent the early stages of Alzheimer’s disease is to enter clinical trials. The number of people with dementia is steadily increasing. 67 more words


My brain feels sticky, I must need more sleep

I meant to write this yesterday, but I was taking a slug day.  I just visited with friends and Leif and the spud on the phone after school.  291 more words

The (re) Education Of Ms Janie Jones

UCLA Study: Simple Blood Test Could Be Developed To Diagnose Alzheimer's

LOS ANGELES (CBSLA.com) — A study has found the first evidence suggesting that a simple blood test could be used to diagnose a patient with Alzheimer’s disease, UCLA researchers reported Thursday. 318 more words


Detecting Alzheimer's Disease Early

A new, noninvasive eye test could someday lead to the detection of Alzheimer’s disease in its earliest stages. The test may allow patients to start treatment earlier, and it could also hasten the development of new Alzheimer’s drugs. 730 more words


Extra copy of miRNA-155 may be key to elevated beta-amyloid protein in brain of individuals with Down syndrome

From Sanford-Burnham Beaker:

Why people with Down syndrome invariably develop Alzheimer’s disease

by Susan Gammon, Ph.D. on October 23, 2014 at 12:32 pm

Amyloid plaques are found in the brains of people with Down syndrome and Alzheimer’s disease.

641 more words

Quantifying the amount and structure of beta-amyloid that is the most harmful to neurons.

The peptide, a small protein, beta-amyloid is strongly associated with Alzheimer’s disease; however, researchers are still looking for unequivocal proof that this peptide is the causal agent of the onset and development of the disease. 503 more words


Substance involved in Alzheimer’s can reverse paralysis in mice with multiple sclerosis

10 AUG 2012
STANFORD, Calif. — A molecule widely assailed as the chief culprit in Alzheimer’s disease unexpectedly reverses paralysis and inflammation in several distinct animal models of a different disorder — multiple sclerosis, Stanford University School of Medicine researchers have found. 1,278 more words

Missed - Medical Breakthroughs